Current role of ultrasound for the management of hepatocellular carcinoma

doi:10.3748/wjg.14.1710

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 11

This Article

(0)

(5433)

(40)

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Topic Highlight

World J Gastroenterol. Mar 21, 2008; 14(11): 1710-1719
Published online Mar 21, 2008. doi: 10.3748/wjg.14.1710

Full Size Figure Download Figure

Figure 3 Assessment of therapeutic response after PEI for HCC. A: Contrast-enhanced CT with dynamic study; B: Contrast-enhanced US (Advanced Dynamic Flow with Levovist). Contrast-enhanced CT showed enhancement appearance which needed additional treatment within the treated area (arrow), and contrast-enhanced US could demonstrate a similar finding. Arrow heads: Lipiodol.

Citation: Maruyama H, Yoshikawa M, Yokosuka O. Current role of ultrasound for the management of hepatocellular carcinoma. World J Gastroenterol 2008; 14(11): 1710-1719
URL: https://www.wjgnet.com/1007-9327/full/v14/i11/1710.htm
DOI: https://dx.doi.org/10.3748/wjg.14.1710

Maruyama H, Yoshikawa M, Yokosuka O. Current role of ultrasound for the management of hepatocellular carcinoma. World J Gastroenterol 2008; 14(11): 1710-1719 [PMID: 18350602 DOI: 10.3748/wjg.14.1710]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.